求助文献的Supplementary Appendix
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy
PMID: 33596362
DOI: 10.1056/NEJMc2030164
不知道邀请谁？试试他们
Chong EA, Ruella M, Schuster SJ; Lymphoma Program Investigators at the University of Pennsylvania. Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy. N Engl J Med. 2021 Feb 18;384(7):673-674.
谢谢
